Sensitization to contact allergens requires activation of the innate immune system by endogenous danger signals. However, the mechanisms through which contact allergens activate innate signaling pathways are incompletely understood. In this study, we demonstrate that mice lacking the adenosine triphosphate (ATP) receptor P2X 7 are resistant to contact hypersensitivity (CHS). P2X 7 -deficient dendritic cells fail to induce sensitization to contact allergens and do not release IL-1 in response to lipopolysaccharide (LPS) and ATP. These defects are restored by pretreatment with LPS and alum in an NLRP3-and ASCdependent manner. Whereas pretreatment of wild-type mice with P2X 7 antagonists, the ATP-degrading enzyme apyrase or IL-1 receptor antagonist, prevents CHS, IL-1 injection restores CHS in P2X 7 -deficient mice. Thus, P2X 7 is a crucial receptor for extracellular ATP released in skin in response to contact allergens. The lack of P2X 7 triggering prevents IL-1 release, which is an essential step in the sensitization process. Interference with P2X 7 signaling may be a promising strategy for the prevention of allergic contact dermatitis.
Allergic contact dermatitis (ACD) is a T cellmediated inflammatory skin disease most fre quently caused by low molecular weight electrophilic chemicals or metal ions. Activation of DCs by contact allergens is a prerequisite for the induction of the pathogenic skinspecific T cell response (Martin and Jakob, 2008; Sigmundsdottir and Butcher, 2008) .
DC activation proceeds via a broad variety of germlineencoded innate immune receptors, in particular the pattern recognition receptors, Tolllike receptors (TLRs) and NODlike recep tors (NLRs; Kawai and Akira, 2009; Martinon et al., 2009; Palm and Medzhitov, 2009 ). TLR and NLR recognize pathogenassociated mo lecular patterns as well as endogenous danger signals (Tsan and Gao, 2004; Jiang et al., 2006; Palm and Medzhitov, 2009 ) associated with tissue destruction, termed damageassociated molecular patterns (Seong and Matzinger, 2004) .
Triggering of pattern recognition receptors by pathogenassociated molecular patterns or damageassociated molecular patterns leads to an inflammatory response involving the production of proinflammatory cytokines, including IL1, chemokines, and antimicrobial peptides.
Inflammatory responses induced by contact allergens in the skin share many features with the innate immune responses to pathogens (Freudenberg et al., 2009 ). In the mouse con tact hypersensitivity (CHS) model, we have re cently demonstrated a critical role for TLR2 and TLR4 in the DCmediated sensitization process . Moreover, contact allergens trigger oxidative stress and antioxidant responses (Matsue et al., 2003; Kim et al., 2008; Natsch and Emter, 2008; Ade et al., 2009 ).
Thus, ATP is an important endogenous mediator in inflam mation. It was recently shown that P2X 7 triggering on DCs by ATP derived from dying tumor cells is a prerequisite for IL1-dependent antitumor responses, and this response was dependent on the NLRP3 inflammasome and caspase1 (Ghiringhelli et al., 2009) . Furthermore, P2X 7 activation on DCs is important in DCmediated airway inflammation (Idzko et al., 2007) . A proin flammatory role for ATP in CHS was suggested by the finding that injection of nonhydrolyzable ATPS into mice before their sensitization resulted in increased ear swelling responses (Granstein et al., 2005) . Interestingly, contact allergens can trigger the release of ATP from keratinocytes and DCs, and it was shown that ATP release from keratinocytes stimulates Langerhans cells (Mizumoto et al., 2002) . However, the mechanisms by which ATP triggers inflammatory responses in CHS were unknown.
In this study, we have investigated the putative role of the ATP receptor P2X 7 in CHS in vivo, including its mode of action. Using mice lacking P2X 7 or WT mice treated with the P2X 7 antagonist KN62 (Baraldi et al., 2004) or the ATP degrading enzyme apyrase, we demonstrate for the first time that P2X 7 is essential for the induction of CHS by contact al lergens in mice. We observed ATP release in the skin upon 2,4,6trinitrochloro1benzene (TNCB) painting, indicating indirect contact allergen-dependent P2X 7 triggering via in duction of ATP release in the skin. In addition, we show by cell transfer experiments that expression of P2X 7 on DCs is crucial for the sensitization but not for the effector phase of CHS. The sensitization defect of P2X 7 / DCs can be by passed by treatment with the NLRP3 inflammasome activa tor alum (Eisenbarth et al., 2008, Franchi and Núñez, 2008; Kool et al., 2008; Li et al., 2008) . However, alum did not restore the absent sensitization capacity of NLRP3 / (Martinon et al., 2006) or ASC / (Sutterwala et al., 2006) DCs, indicating a link between ATPmediated P2X 7 triggering and NLRP3 inflammasome activation in IL1 release. The crucial role of this cytokine in CHS was suggested by the prevention of CHS after injection of mice with the IL1 re ceptor (IL1R) antagonist (IL1Ra) anakinra, which is used in the treatment of inflammatory diseases such as gout (So et al., 2007; Gabay et al., 2010) , or the impaired CHS in IL1R / mice. Most importantly, injection of IL1 into P2X 7 / mice restored their CHS response. Thus, interfering with purinergic signaling via P2X 7 may be a promising ap proach for the prevention of ACD.
RESULTS
Mice deficient for the purinergic receptor P2X 7 are resistant to CHS To study the role of extracellular ATP in CHS, we tested C57BL/6 WT and P2X 7 deficient (P2X 7 / ) mice for their ear swelling reaction to epicutaneous sensitization with the contact allergen TNCB. Mice were treated on the abdominal skin followed by elicitation of CHS on day 5 by application of TNCB to the ear skin. The increase in ear thickness was measured 24 h after elicita tion. Although WT mice developed a normal earswelling re sponse, P2X 7 / mice did not develop TNCBinduced CHS They also activate the NLRP3 inflammasome (Sutterwala et al., 2006; Watanabe et al., 2007) , a cytosolic platform which activates caspase1 for the processing of pro-IL1 and pro-IL18 produced, e.g., by keratinocytes and DC in response to various stimuli, including TLR, NLR, and the purinergic re ceptor P2X 7 (Ferrari et al., 2006; Martinon et al., 2009; Surprenant and North, 2009) . These cytokines play a key role in the sensitization phase of CHS and are key mediators of Langerhans cell migration from the skin to the draining lymph nodes (Shornick et al., 1996; Antonopoulos et al., 2001 Antonopoulos et al., , 2008 Cumberbatch et al., 2001 ). The molecular mechanisms by which contact allergens activate these innate immune and stress pathways are largely unknown. Recent evidence suggests that endogenous ligands such as fragments of hyaluronic acid may trigger TLR2 and TLR4 in CHS Freudenberg et al., 2009) . Similarly, extracellular nucleotides such as ATP released by stressed or damaged cells are endogenous danger signals that can activate innate immune responses. There are two families of purinergic receptors (P2R), i.e., P2Y and P2X (North and Surprenant, 2000; Abbracchio et al., 2006; Burnstock, 2008) . P2Y receptors are G protein-coupled receptors, and P2X re ceptors are ligandgated ion channels. The transmembrane ATP receptor P2X 7 has been implicated in the posttransla tional processing of pro-IL1 and pro-IL18 via activation of the NLRP3 inflammasome (Solle et al., 2001; Ferrari et al., 2006; Dinarello, 2009; Martinon et al., 2009; Surprenant and North, 2009 ). This receptor is expressed on mouse DCs. P2X 7 deficient DCs are severely impaired in IL1 release and stimulation of antigenspecific T cells (Mutini et al., 1999) .
ATP is the main energy carrier in cells with a cytosolic concentration of 3-10 mM. Under homeostatic conditions, extracellular ATP levels are as low as 10 nM and are tightly regulated by ectonucleotidases such as CD39 and CD73, which dephosphorylate ATP to ADP, AMP, and adenosine (Ferrari et al., 2006; Surprenant and North, 2009) . Adenosine has immunoregulatory functions in CHS (Ring et al., 2009 ). However, under pathological conditions such as hypoxia, trauma, viral, and bacterial infection and in flammation, extracellular concentrations of ATP can be ele vated as the result of active processes or passive leakage from damaged or dying cells. The concomitant downregulation of nucleotidases causes additional accumulation of extracellular nucleotides (Robson et al., 1997; Lazarowski et al., 2003) .
ATPmediated K + efflux from cells is triggered by en gagement of P2X 7 and is crucial for LPSmediated IL1 release from human macrophages (Ferrari et al., 1997) . More over, LPSprimed macrophages from P2X 7 / mice fail to secrete mature IL1 because of their inability to process the immature pro form. This defect can be repaired by treatment with nigericin (Solle et al., 2001 ), a P2X 7 independent acti vator of the NLRP3 inflammasome. The NLRP3 inflamma some is activated in response to ATP and is required for posttranslational IL processing (Mariathasan et al., 2006; Dinarello, 2009 ).
Thus, the role of the P2X 7 receptor on DCs in the induction and/or elicitation of CHS was assessed. BMderived DCs (BMDCs) of WT and P2X 7 / mice were modified with TNBS and subse quently injected i.c. (intracutaneously) into WT recipients as described previ ously . TNBS modified WT BMDCs effectively sensitized WT recipients (Fig. 2 A) . In contrast, TNBSmodified P2X 7 / BMDCs failed to sensitize WT mice under identical conditions. Together with the finding that TNBSmodified WT BMDCs were able to readily sen sitize P2X 7 / recipients ( Fig. 2 B) , these data indicate that expression of P2X 7 on DCs is essential during the sensitization phase but not during the effector phase of CHS.
Alum pretreatment restores the sensitization capacity of P2X 7 -deficient BMDCs The failure of P2X 7 / BMDCs to induce sensitization may be caused by their failure to produce mature IL1 via the NLRP3 inflammasome (Ferrari et al., 2006; Mariathasan et al., 2006; Surprenant and North, 2009 ). Therefore, we bypassed the need for P2X 7 triggering with alum, a potent P2X 7 independent activator of the NLRP3 inflammasome (Eisenbarth et al., 2008, Franchi and Núñez, 2008; Kool et al., 2008; Li et al., 2008) . BMDCs were pre treated with alum before adoptive transfer. TNBSmodified (Fig. 1 A) . Similar results were obtained for the contact allergen oxazolone (Fig. 1 B) . In contrast, P2X 7 deficient mice developed normal ear swelling in response to the irritant croton oil (Fig. 1 C) . These results identify a crucial role for the ATPgated cation channel P2X 7 in CHS induced by contact allergens. The results from ear thickness measurements are supported by histol ogy of the ear skin. In contrast to P2X 7 / mice, the ear skin of WT mice treated with TNCB shows a significant swelling and a more pronounced inflammatory infiltrate (Fig. 1 D) . are required in DCs for successful sensitization. To analyze the role of NLRP3 in P2X 7 mediated IL1 pro cessing, WT or NLRP3 / BMDCs were stimulated in vitro with LPS and alum or with LPS and ATP. Neither alum nor ATP stimulation increased the LPSinduced IL1 secretion from NLRP3 / BMDC mice in contrast to BMDCs from WT mice (Fig. 3 C) . These data demonstrate that the P2X 7 / dependent IL1 release is mediated via the NLRP3 inflam masome and confirm the important role of NLRP3 in alummediated IL1 processing (Eisenbarth et al., 2008; Kool et al., 2008; Li et al., 2008) . IL6 release was triggered effi ciently in both WT and NLRP3 / BMDCs, showing that there is no general functional defect of NLRP3 / BMDCs (unpublished data).
P2X 7
/ BMDCs fail to process and secrete mature IL-1 To further address the functional consequence of P2X 7 de ficiency in DCs, WT and P2X 7 / BMDCs were analyzed for the production and secretion of pro-and mature IL1 by West ern blotting (Fig. 4 A) and for secreted IL1 by ELISA (Fig. 4 B ) in response to LPS and ATP in vitro. This cytokine is essential for the sensitization process in CHS (Shornick et al., 1996; Antonopoulos et al., 2001 Antonopoulos et al., , 2008 Cumberbatch et al., 2001 ). Both WT and P2X 7 / BMDCs produced similar amounts of pro-IL1 in response to LPS (Fig. 4 A) , but only WT BMDCs se creted mature IL1 when challenged with LPS and ATP, whereas P2X 7 / BMDCs did not (Fig. 4 B) . These data show that induction of IL1 release by TNCB is crucially dependent on ATPmediated triggering of P2X 7 . It is worth noting that in both WT and P2X 7 / BMDCs, ATP alone was able to effi ciently induce pro-IL1 (Fig. 4 A) . This points to a P2X 7 / independent effect on pro-IL1 production. When BMDCs from both mouse strains were treated with graded concentrations of alum alone in vitro, no IL1 release was observed (Fig. 4 C) . However, the addition of 1 µg/ml LPS resulted in a dose dependent IL1 release from BMDCs of WT and P2X 7 / and alumpretreated P2X 7 / BMDCs regained their sensi tizing potential upon transfer into both WT and P2X 7 / recipi ents (Fig. 2 C) . Alum pretreatment of WT BMDCs did not significantly alter their sensitizing potential (Fig. 2 D) . These data further support the assumption that P2X 7 on DCs is man datory for efficient induction of CHS and acts via processing and release of inflammasomedependent cytokines such as IL1 (Ferrari et al., 2006; Mariathasan et al., 2006; Martinon et al., 2009; Surprenant and North, 2009 ).
Alum pretreatment fails to restore the sensitization capacity of NLRP3-or ASC-deficient BMDCs
To analyze the role of the NLRP3 inflammasome in DCs and the mechanism of the P2X 7 bypass with alum, WT mice were sensitized with NLRP3 / (Martinon et al., 2006) BMDCs in comparison with WT and P2X 7 / BMDCs with and without alum pretreatment (Fig. 3 A) . No CHS was elicited by TNCB challenge in mice sensitized with unmodified con trol DCs or alum pretreated control DCs of all three mouse strains. Moreover, we demonstrate that the lack of NLRP3 in BMDCs modified with TNBS abrogates their sensitization capacity. This defect was not prevented by alum pretreatment, indicating that the alum bypass of P2X 7 is mediated by the NLRP3 inflammasome. In addition, we used BMDCs from ASC / mice (Sutterwala et al., 2006) for sensitization (Fig. 3 B) . As shown for NLRP3 / BMDCs, TNBSmodified ASC / BMDCs also failed to sensitize WT mice for CHS, a defect which again could not be bypassed by alum pretreatment. These data support the notion that the NLRP3 inflamma some is important in CHS (Sutterwala et al., 2006; Watanabe et al., 2007) and demonstrate that functional ASC and NLRP3 imaging (Edinger et al., 2003) revealed that TNCB rapidly triggers ATP release, as detected by ATPdependent luciferin induced bioluminescence from HEK293pmeLUC cells (Pellegatti et al., 2008) after painting of the ear skin of mice (Fig. 5) . These data reveal that P2X 7 is triggered by the en dogenous danger signal ATP that is released from cells in the skin after TNCB treatment.
P2X 7 antagonists or removal of extracellular ATP prevents CHS To further investigate the role of the P2X 7 receptor in CHS in vivo, experiments with the P2X 7 receptor antagonist KN62 (Baraldi et al., 2004) were performed in WT mice. Re cipients were injected with KN62 into the left ear pinna, followed by sensitization with TNCB on the same ear 4 h later. CHS was elicited on day 5 with TNCB on the right ear, and the increase in ear thickness was measured 24 h after elic itation. As depicted in Fig. 6 A, pretreatment with KN62 before TNCB sensitization led to abrogation of CHS in WT mice. This effect was dose and time dependent (Fig. S1 ). Sim ilar results were obtained with the purinergic receptor antag onist suramin ( Fig. S2 ; Baraldi et al., 2004) . These data again indicate an essential role for P2X 7 receptor signaling in CHS. mice (Fig. 4 D) . These results and the results shown in Fig. 3 show a link between LPSinduced pro-IL1 production and ATP and P2X 7 dependent IL1 processing and release. An important finding is that ATP triggering of P2X 7 can be replaced by alum treatment of the BMDCs, which results in LPSinduced IL1 production and release of processed IL1 not only in WT but also in P2X 7 / BMDCs (Fig. 4, C and D) . Importantly, the alum effect is no longer visible when BMDCs from NLRP3 / or ASC / mice are used for sensitization in CHS (Fig. 3, A and B) . Moreover, alum also fails to restore defective LPSinduced IL1 release in NLRP3 / BMDCs in vitro (Fig. 3 C) . These data support the notion that defective IL1 release of P2X 7 / DCs is responsible for their failure to sensitize mice for CHS. They also strongly suggest that contact allergen-induced ATP triggering of P2X 7 leads to IL1 processing via the NLRP3 inflammasome, as demonstrated in other systems (Ferrari et al., 2006; Mariathasan et al., 2006; Idzko et al., 2007; Ghiringhelli et al., 2009; Surprenant and North, 2009 ).
TNCB triggers ATP release in vivo in mouse skin
We next analyzed whether ATP is released in the skin after application of the contact allergen TNCB. Bioluminescence / , and WT BMDCs (A) or ASC / and WT BMDCs (B) were TNBS modified and alum pretreated where indicated, and the experiment was performed as described in Fig. 2 . The data represent the mean increase in ear thickness of groups of five mice ± SD. One representative of three (NLRP3) and two (ASC) independent experiments is shown (**, P < 0.005; ***, P < 0.001). (C) NLRP3 / and WT BMDCs were treated with 0.1 µg/ml LPS, 1.25 mM ATP, 80 µg/ml alum, or the indicated combination of two stimuli for 12 h. IL-1 secretion was determined by ELISA. Data represent the mean of triplicate measurements ± SD and are representative for two independent experiments (*, P < 0.05; **, P < 0.005; ***, P < 0.001).
These data underline the role of IL1R signaling and the crucial pathogenic role of IL1 for the sensitization to con tact allergens (Shornick et al., 1996; Antonopoulos et al., 2001 Antonopoulos et al., , 2008 Cumberbatch et al., 2001 ).
DISCUSSION
The mechanisms by which contact allergens activate innate immune and stress responses in skin are only poorly understood. We have recently demon strated a crucial role for the innate immune receptors TLR2 and TLR4 and the cytokine receptor IL12R2 in the sensiti zation phase of CHS . These receptors are indirectly triggered by contact allergens via induction of en dogenous ligands such as fragments of the extracellular matrix component hyaluronic acid. So far, only Ni 2+ has been identi fied as a contact allergen that directly triggers human TLR4 by binding to conserved histidine residues that are not present in mouse TLR4 (Schmidt et al., 2010) . This explains why CHS to Ni 2+ in mice requires coapplication of adjuvants.
Besides the TLRs, a role for the NLRP3 inflammasome in CHS has been demonstrated (Sutterwala et al., 2006; Watanabe et al., 2007) . In the present study, we show that P2X 7 signaling in DCs is a crucial step in the sensitization phase of CHS. Inter estingly, irritant contact dermatitis induced by croton oil is not affected in P2X 7 / mice. However, these mice are resistant to contact allergen-induced CHS. P2X 7 / DCs are incapable of sensitizing WT mice for CHS, whereas WT DCs efficiently sensitize P2X 7 / mice. The reconstitution of the sensitization capacity of P2X 7 / DCs by pretreatment with alum, a P2X 7 independent activator of the NLRP3 inflammasome (Eisenbarth et al., 2008, Franchi and Núñez, 2008; Kool et al., 2008; Li et al., 2008) To assess the role of endogenously released ATP in CHS, WT mice were injected with apyrase, an ATPdegrading enzyme, to remove ATP from the extracellular space (Idzko et al., 2007) using the same approach as described for KN62 (Fig. 6 A) . Injection of apyrase into the ear pinna before sensitization pre vented CHS in WT mice (Fig. 6 B) . A dose and timedependent reduction of the ear swelling response was observed (Fig. S3) . These results underline the crucial role for the release of extracellular ATP in the sensitization phase of CHS.
IL-1R blockade or deficiency abrogates CHS, whereas IL-1 restores CHS in P2X 7
/ mice Finally, to assess the role of IL1 in CHS, we neutralized the effects of this cytokine by i.v. injection of the recombinant IL1Ra anakinra before sensitization of WT mice with TNCB. After ear challenge, we observed that anakinra treatment effi ciently prevented the CHS response (Fig. 7 A) . When we tried to induce CHS in IL1R / mice, we observed a similar effect. In contrast to IL18 / mice, CHS was significantly reduced (Fig. 7 B) . Because IL1R signaling is not confined to IL1, we addressed the role of this cytokine by pretreat ment of mice by IL1 injection before sensitization. Al though this treatment did not affect the CHS response in WT mice, it fully restored it in the P2X 7 / mice (Fig. 7 C) . Surprenant and North, 2009) , is fur ther supported by our in vitro find ings. Stimulation of WT BMDCs with LPS and ATP results in production and secretion of mature IL1, whereas IL1 processing and secretion is ab rogated in P2X 7 / BMDCs. The fact that we can restore this defect with the inflammasome activator alum, which bypasses P2X 7 by direct activation of the NLRP3 inflammasome (Eisenbarth et al., 2008, Franchi and Núñez, 2008; Kool et al., 2008; Li et al., 2008) , and the lack of IL1 release from NLRP3 / DCs after stimulation with LPS and ATP reveal a functional link between ATP, P2X 7 , and the NLRP3 inflammasome in IL1 processing and secretion in the sen sitization phase of CHS. Similar results were reported for LPSprimed macrophages from P2X 7 / mice, which secrete IL1 when pretreated with the inflammasome activator ni gericin (Solle et al., 2001) . This is further supported by our results demonstrating a failure of TNBSmodified BMDCs from ASC / and NLRP3 / mice (Martinon et al., 2006; Sutterwala et al., 2006) to sensitize WT mice. In contrast to the results with P2X 7 BMDCs, alum pretreatment of these DCs fails to restore their sensitizing capacity.
Interestingly, our data support the notion that IL1 as a rapidly induced pathogenic cytokine in the sensitization phase of CHS (Enk and Katz, 1992 ) plays a crucial role. Keratinocytes and suggests a P2X 7 dependent pathway in the processing and se cretion of the key cytokines IL1 and IL18 in CHS (Shornick et al., 1996; Antonopoulos et al., 2001 Antonopoulos et al., , 2008 Cumberbatch et al., 2001 ). P2X 7 mediated K + efflux from the cell can activate the NLRP3 inflammasome and caspase1, which is a require ment for IL1 processing and secretion (Solle et al., 2001 , Mariathasan et al., 2006 Dinarello, 2009) . Similar effects are ob served upon depletion of intracellular K + by nigericin and mai totoxin (Ferrari et al., 2006; Mariathasan et al., 2006; Surprenant and North, 2009 ). Our findings suggest that P2X 7 is involved in contact allergen-induced and NLRP3 inflammasome-dependent IL1 release.
The previously reported link between P2X 7 and post translational IL1 processing, which involves the NLRP3 inflammasome (Ferrari et al., 2006; Mariathasan et al., 2006; Idzko et al., 2007; Ghiringhelli et al., 2009;  In the light of recent data showing that ATP can activate regulatory T cells and control CHS (Ring et al., 2010) , a dual role for ATP in inflammation and immunoregulation becomes evident. It remains to be determined how the balance between proinflammatory and regulatory immune responses is regu lated. The kinetics of these responses, the target cells, and the purinergic receptors involved may all play a role.
Our study identifies ATP triggering of P2X 7 on DCs as a crucial step in the induction of skin inflammation by contact allergens but not skin irritants such as croton oil. Similar to our findings with indirect TLR2 and TLR4 triggering by contact allergens such as TNCB, oxazolone, and FITC, via in duction of endogenous TLR ligands , we provide evidence that P2X 7 activation by contact allergens is also indirect. We show that TNCB rapidly induces the release of the P2X 7 agonist ATP in the skin. We demonstrate that TNCBinduced CHS can be readily prevented by injection of the P2X 7 antagonist KN62 and the purinergic receptor antagonist suramin or by the ATPdegrading enzyme apyrase. Further studies will show whether P2X 7 specific antagonists are also effective in the control of established CHS. In this context, our finding that treatment of mice with the IL1Ra
Langerhans cells are sources for IL1 in the skin. A recent in vivo imaging study identified CD45 + CD11b + myeloid leukocytes as primary sources for IL1 by monitoring mes senger RNA induction in vivo (Matsushima et al., 2010) . In contrast to the failure to sensitize WT mice treated with the IL1Ra anakinra or the absence of CHS in IL1R / mice, CHS to TNCB was normal in IL18 / mice. More over, pretreatment of P2X 7 / mice with IL1 fully restored CHS. These results show the crucial role of IL1 in the sensitization to TNCB. The extent of IL1 messenger RNA induction correlates with the dose as well as with strength of the contact allergen (Lass et al., 2010) . Interest ingly, it was shown that CHS to DNFB (2,4dinitrofluoro benzene) is also dependent on IL18 (Klekotka et al., 2010) . In this study, a role for IL1R on radiosensitive bone marrowderived cells and for IL18 in radioresistant hostderived cells was demonstrated in bone marrow chimeras. Our findings on the role of IL1 are in line with the study by Antonopoulos et al. (2008) , who showed that deficient CHS in caspase1 / mice can be restored by pretreatment with IL1 but not with IL18. The authors concluded that IL18 acts upstream of IL1. / mice were injected with IL- in PBS/0.1% BSA or vehicle control 30 min before sensitization in the dorsum of the left ear. Mice were sensitized by topical application of 3% TNCB on the dorsum of the right ear on day 0. Challenge was performed on day 5 with 1% TNCB on the dorsum of the left ear. One experiment was performed. (A-C) Data represent the mean increase in ear thickness ± SD of groups of five mice (**, P < 0.005; ***, P < 0.001).
The P2X 7 receptor antagonist KN62 (SigmaAldrich) was dissolved in DMSO at 7.14 mg/ml. Mice were injected with KN62 diluted in 71.4 µg/ml PBS, and 50 µl was injected into the pinna of the left ear 4 h before sensitization unless indicated otherwise. Apyrase (2 U potato apyrase grade 7 [Sigma Aldrich] in 50 µl PBS) was injected into the ear pinna immediately before sen sitization unless indicated otherwise. Mice were sensitized with 3% TNCB on the same ear and challenged 5 d later on the right ear with 1% TNCB. 24h earswelling responses were measured. Anakinra Kineret (Amgen) was injected at a dose of 200 µg/mouse i.p. in 200 µl PBS on days 5, 3, and 1 before sensitiza tion. The optimal doses and the timing for KN62 and apyrase treatment were determined as shown in Figs. S1 and S3. IL1 (50 µg in 30 µl PBS/0.1% BSA) or PBS/BSA as vehicle control was injected into WT and P2X 7 / mice 30 min before sensitization in the dorsum of the left ear as described previously (Antonopoulos et al., 2008) . Mice were sensitized by topical application of 20 µl of 3% TNCB on the dorsum of the left ear on day 0. Challenge was performed on day 5 with 20 µl of 1% TNCB on the dorsum of the right ear.
Histology of the skin. Ears from vehicle or allergensensitized mice were removed 24 h after allergen ear challenge and fixed in 3.7% buffered formal dehyde. Organ slices of 5 µm were prepared and stained with hematoxylin and eosin (H&E).
Induction of irritant contact dermatitis. Mice were painted on both ears with 20 µl of 1% croton oil (SigmaAldrich) in acetone/olive oil (4:1). The ear thickness was measured before and 24 h after application of croton oil.
Alum pretreatment of BMDCs before adoptive transfer. BMDCs were harvested on day 7 and modified with TNBS as described previously . For alum stimulation, BMDCs were incubated for 2 h at 37°C in RP10 containing 240 µg/ml aluminum hydroxide (diluted 1:166.7; Imject Alum; Thermo Fisher Scientific) unless indicated otherwise. For NLRP3 / and ASC / BMDC transfers into WT mice, 80 µg/ml alum was used to avoid stimulation of recipient WT cells caused by alum carryover. Cells were washed three times in PBS before adoptive transfer by i.c. injection.
In vivo bioluminescence imaging of ATP release. In vivo biolumines cence imaging was performed as previously described (Edinger et al., 2003) . In brief, 5 × 10 6 HEK293pmeLUC cells (Pellegatti et al., 2008) were in jected into the ear skin in 50 µl PBS. Mice were treated 24 h after cell transfer with the contact allergen TNCB (20 µl of 3% TNCB/acetone), the vehicle control acetone, or by injection of 50 µl of 1.25 mM ATP/PBS as a positive control, followed by i.p. injection of luciferin. 10 min later, the mice were imaged with an exposure time of 5 min with an IVIS 100 chargecoupled device imaging system (Xenogen) and Igor Pro Carbon (WaveMetrics).
In vitro stimulation of DCs and IL-1 measurement. Stimulation of 10 6 BMDCs was performed in 500 µl RP10 for 12 h with 1 µg/ml LPS in the presence or absence of 5 mM ATP or the corresponding controls. No significant differences in the viability of BMDCs from WT and P2X 7 / DCs were observed by propidium iodide/annexinV staining. Supernatants were used for Western blotting and ELISA to measure IL1. ELISA (OptEIA; BD) was performed according to the manufacturer's recommenda tions. Peritoneal macrophages were prepared and stimulated with LPS and ATP as described previously (Metkar et al., 2008) , and the supernatant was used as positive control for Western blots. For alum stimulation, BMDCs were incu bated for 12 h at 37°C in RP10 containing graded concentrations of alumi num hydroxide in the presence or absence of 0.1 µg LPS.
Statistical analysis. Statistical analysis was conducted using oneway analy sis of variance with Tukey's multiple comparison post test and Prism version 5.00 (GraphPad Software, Inc.). Data are shown as means ± SD. Differences between groups as marked by asterisks were statistically significant at P < 0.05 (*), P < 0.005 (**), or P < 0.001 (***).
Online supplemental material. Fig. S1 shows the dose titration and time kinetics for the P2X 7 antagonist KN62. Fig. S2 shows suppression of the anakinra efficiently prevents CHS opens the possibility to test its efficiency in patients with ACD.
The fact that TLR2 and TLR4, P2X 7 , or NLPR3 and ASC must be functional on DCs to enable them to sensitize mice for CHS and that the lack of function of one of these pathways is sufficient to abrogate their sensitization potential supports our concept of an essential collaborative action of these pathways in CHS (Freudenberg et al., 2009) . The essen tial role of the DC is explained by its unique function as the cell type that migrates from the inflamed skin to the lymph nodes, communicates the activation of the innate immune system to contact allergen-specific T cells, and directs effector T cells to the skin (Dudda and Martin, 2004; Edele et al., 2007; Sigmundsdottir and Butcher, 2008) .
Our study may open new perspectives for the treatment of ACD with available antagonists of the P2X 7 receptor, as re cently reported for allergic airway inflammation (Idzko et al., 2007) . So far, our data suggest that P2X 7 antagonists may pre vent sensitization to contact allergens. It remains to be studied whether P2X 7 signaling also plays a role in the elicitation phase or in chronic contact dermatitis.
MATERIALS AND METHODS
Mice. C57BL/6 WT, C57BL/6 P2X 7 / (Solle et al., 2001) , and ASC / mice (Sutterwala et al., 2006) were bred at the animal facility of the University Medical Center Freiburg under specific pathogenfree conditions. P2X 7 / mice were purchased from The Jackson Laboratory. NLRP3 / mice (Martinon et al., 2006) were received from M. Kopf (Swiss Federal Institute of Technology Zurich, Zurich, Switzerland) with permission from J. Tschopp (University of Lausanne, Lausanne, Switzerland). IL1R / (Labow et al., 1997) and IL18 / mice (Wei et al., 1999 ) on C57BL/6 background were a gift from M. Freuden berg (MaxPlanckInstitute of Immunobiology, Freiburg, Germany). All of the experimental procedures were in accordance with institutional, state, and federal guidelines on animal welfare. The animal experiments were approved by the Regierungspräsidium Freiburg and supervised by the Animal Protection Repre sentatives of the University Medical Center Freiburg.
Chemicals and reagents. TNBS, FITC, oxazolone, and croton oil were purchased from SigmaAldrich. TNCB was purchased from VeZerf Laborsyn thesen GmbH. LPS of Salmonella abortus equi was purchased from Enzo Life Sciences, Inc. IL1 ELISA was purchased from BD (OptEIA ELISA set). Recombinant IL1 was purchased from R&D Systems. Flow cytometry was performed as described previously on a FACScan instrument with CellQuest Pro software (BD).
Generation of BMDCs.
BMDCs were prepared as previously described . Overall DC viability was not significantly influenced by the lack of P2X 7 as controlled by growth rate and cell yield in DC cultures from P2X 7 / compared with WT mice.
Immunization and induction of CHS. Mice were sensitized by painting the abdominal skin with 100 µl of 3% TNCB/acetone or acetone alone as vehicle control on day 0. Epicutaneous application of 20 µl of 1% TNCB on the dorsum of both ears on day 5 was used for elicitation. Alternatively, mice were sensitized by i.c. injection of 3 × 10 5 unmodified or TNBSmodified BMDCs in 2 × 50 µl PBS into two sites of the shaved abdomen followed by elicitation on day 5 by painting the dorsum of both ears with 1% TNCB. CHS to oxazolone was induced by sensitization with 150 µl of 3% oxazolone in ethanol, followed by ear challenge with 20 µl of 1% oxazolone/ethanol 6 d later. Ear measurement was performed before and 24 h after challenge using an engineer's thickness gauge (Mitutoyo).
